Gabriel Bien-Willner, MD, PhD
Medical Director, MoIDX, Palmetto
Dr. Bien-Willner is the Medical Director of the MolDX program at Palmetto GBA, a Medicare Administrative Contractor (MAC). He is a leader in the Precision Medicine space and practices as a Board-certified Anatomic Pathologist and Molecular Genetic Pathologist. Dr. Bien-Willner received his MD and PhD degrees from Baylor College of Medicine, with a PhD in Human Molecular Genetics. He completed his residency, fellowship, and attained a faculty appointment at Washington University in St. Louis prior to leadership roles in laboratory and biotech companies before joining Palmetto GBA.
![](https://ahip.imgix.net/headshots/AHIP2023-Speaker-AbstractPlaceholder-640X520.png?auto=format%2Ccompress&crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=320&ixlib=php-3.3.1&w=400&s=9dc8efd76fbea4e58b04b85362554c7d)